-
1
-
-
0027862597
-
Taxol: A history of pharmaceutical development and current pharmaceutical concerns
-
Adams, J.D., Flora, K.P., Goldspeil, B.R., Wilson, J.W., & Arbuck, S.G.I. (1993). Taxol: A history of pharmaceutical development and current pharmaceutical concerns. Journal of the National Cancer Institute. Monographs, 15, 141-147.
-
(1993)
Journal of the National Cancer Institute. Monographs
, vol.15
, pp. 141-147
-
-
Adams, J.D.1
Flora, K.P.2
Goldspeil, B.R.3
Wilson, J.W.4
Arbuck, S.G.I.5
-
2
-
-
0346434985
-
-
(4th Ed.)
-
Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., & Walter, P. (2002). Molecular biology of the cell (4th ed.). Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK21051
-
(2002)
Molecular Biology of the Cell
-
-
Alberts, B.1
Johnson, A.2
Lewis, J.3
Raff, M.4
Roberts, K.5
Walter, P.6
-
3
-
-
84873277137
-
-
American Society of Health-System Pharmacists
-
American Society of Health-System Pharmacists. (2013). Drug shortage bulletin: Paclitaxel injection. Retrieved from http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=790
-
(2013)
Drug Shortage Bulletin: Paclitaxel Injection
-
-
-
4
-
-
0034731650
-
Description of a short-term Taxol-induced nociceptive neuropathy in rats
-
doi:10.1016/S0006-8993(00)02910-3
-
Authier, N., Gillet, J.P., Fialip, J., Eschalier, A., & Coudore, F. (2000). Description of a short-term Taxol-induced nociceptive neuropathy in rats. Brain Research, 887, 239-249. doi:10.1016/S0006-8993(00)02910-3
-
(2000)
Brain Research
, vol.887
, pp. 239-249
-
-
Authier, N.1
Gillet, J.P.2
Fialip, J.3
Eschalier, A.4
Coudore, F.5
-
5
-
-
79959327217
-
-
7th ed.). Belmont, CA: Brooks/Cole, Cengage Learning
-
Bettelheim, F.A., Brown, W.H., Campbell, M.K., & Farrell, S.O. (2010). Introduction to organic and biochemistry (7th ed.). Belmont, CA: Brooks/Cole, Cengage Learning.
-
(2010)
Introduction to Organic and Biochemistry
-
-
Bettelheim, F.A.1
Brown, W.H.2
Campbell, M.K.3
Farrell, S.O.4
-
7
-
-
84873262575
-
-
Celgene Corporation
-
Celgene Corporation. (2012). Abraxane® (nab-paclitaxel) [Prescribing information]. Retrieved from http://www.abraxane.com/hcp/download/Abraxane_Prescribing_Information.pdf
-
(2012)
Abraxane® (nab-paclitaxel) [Prescribing Information]
-
-
-
8
-
-
29444449451
-
Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions
-
doi:10.1016/S1081-1206(10)61024-1
-
Coors, E.A., Seybold, H., Merk, H.F., & Mahler, V. (2005). Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions. Annals of Allergy, Asthma, and Immunology, 95, 593-599. doi:10.1016/S1081-1206(10)61024-1
-
(2005)
Annals of Allergy, Asthma, and Immunology
, vol.95
, pp. 593-599
-
-
Coors, E.A.1
Seybold, H.2
Merk, H.F.3
Mahler, V.4
-
9
-
-
84863731171
-
U.S. Food and Drug Administration approval overview in MBC
-
doi:10.1200/JCO.2011.39.2613
-
Cortazar, P., Justice, R., Johnson, J., Sridhara, R., Keegan, P., & Pazdur, R. (2012). U.S. Food and Drug Administration approval overview in MBC. Journal of Clinical Oncology, 30, 1705-1711. doi:10.1200/JCO.2011.39.2613
-
(2012)
Journal of Clinical Oncology
, vol.30
, pp. 1705-1711
-
-
Cortazar, P.1
Justice, R.2
Johnson, J.3
Sridhara, R.4
Keegan, P.5
Pazdur, R.6
-
10
-
-
73149105736
-
Nanoparticle albumin-bound (nab)-paclitaxel: Improving efficacy and tolerability by targeted drug delivery in MBC
-
doi:10.1016/S1359-6349(10)70002-1
-
Cortes, J., & Saura, C. (2010). Nanoparticle albumin-bound (nab)-paclitaxel: Improving efficacy and tolerability by targeted drug delivery in MBC. European Journal of Cancer Supplements, 8, 10. doi:10.1016/S1359-6349(10)70002-1
-
(2010)
European Journal of Cancer Supplements
, vol.8
, pp. 10
-
-
Cortes, J.1
Saura, C.2
-
11
-
-
0023630918
-
Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol
-
doi:10.1056/NEJM198710013171404
-
de Groen, P.C., Aksamit, A.J., Rakela, J., Forbes, G.S., & Krom, R.A. (1987). Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. New England Journal of Medicine, 317, 861-866. doi:10.1056/NEJM198710013171404
-
(1987)
New England Journal of Medicine
, vol.317
, pp. 861-866
-
-
de Groen, P.C.1
Aksamit, A.J.2
Rakela, J.3
Forbes, G.S.4
Krom, R.A.5
-
12
-
-
33644753906
-
Increased antitumor activity, intratumoral paclitaxel concentrations, and endothelial cell transport of Cremophor-free, albumin-bound paclitaxel, ABI-007, compared with Cremophor-based paclitaxel
-
doi:10.1158/1078-0432.CCR-05-1634
-
Desai, N., Trieu, V., Yao, Z., Louie, L., Ci, S., Yang, A.,... Soon-Shiong, P. (2006). Increased antitumor activity, intratumoral paclitaxel concentrations, and endothelial cell transport of Cremophor-free, albumin-bound paclitaxel, ABI-007, compared with Cremophor-based paclitaxel. Clinical Cancer Research, 12, 1317-1324. doi:10.1158/1078-0432.CCR-05-1634
-
(2006)
Clinical Cancer Research
, vol.12
, pp. 1317-1324
-
-
Desai, N.1
Trieu, V.2
Yao, Z.3
Louie, L.4
Ci, S.5
Yang, A.6
Soon-Shiong, P.7
-
13
-
-
80052460410
-
Comparing medical cost of care for patients with MBC receiving taxane therapy: Claims analysis
-
Force, R.W., Pugmire, B.A., & Culbertson, V.L. (2010). Comparing medical cost of care for patients with MBC receiving taxane therapy: Claims analysis. American Health and Drug Benefits, 3, 276-284.
-
(2010)
American Health and Drug Benefits
, vol.3
, pp. 276-284
-
-
Force, R.W.1
Pugmire, B.A.2
Culbertson, V.L.3
-
14
-
-
48249135791
-
Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel
-
doi:10.1158/1078-0432.CCR-07-4592
-
Gardner, E.R., Dahut, W.L., Scripture, C.D., Jones, J., Aragon-Ching, J.B., Desai, N., & Figg, W.D. (2008). Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel. Clinical Cancer Research, 14, 4200-4205. doi:10.1158/1078-0432.CCR-07-4592
-
(2008)
Clinical Cancer Research
, vol.14
, pp. 4200-4205
-
-
Gardner, E.R.1
Dahut, W.L.2
Scripture, C.D.3
Jones, J.4
Aragon-Ching, J.B.5
Desai, N.6
Figg, W.D.7
-
15
-
-
0037080432
-
Comparative pharmacokinetics of unbound paclitaxel during 1- and 3-hour infusions
-
Gelderblom, H., Mross, K., ten Tije, A. J., Behringer, D., Mielke, S., van Zomeren, D. M.,... Sparreboom, A. (2002). Comparative pharmacokinetics of unbound paclitaxel during 1- and 3-hour infusions. Journal of Clinical Oncology, 20, 574-581.
-
(2002)
Journal of Clinical Oncology
, vol.20
, pp. 574-581
-
-
Gelderblom, H.1
Mross, K.2
ten Tije, A.J.3
Behringer, D.4
Mielke, S.5
van Zomeren, D.M.6
Sparreboom, A.7
-
16
-
-
0028894301
-
Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans
-
Gianni, L., Kearns, C.M., Giani, A., Capri, G., Vigano, L., Locatelli, A.,... Egorin, M.J. (1995). Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans. Journal of Clinical Oncology, 13, 180-190.
-
(1995)
Journal of Clinical Oncology
, vol.13
, pp. 180-190
-
-
Gianni, L.1
Kearns, C.M.2
Giani, A.3
Capri, G.4
Vigano, L.5
Locatelli, A.6
Egorin, M.J.7
-
17
-
-
84867058051
-
A phase II trial of nab-paclitaxel compared with docetaxel as first-line chemotherapy in patients with metastatic breast cancer: Final analysis of overall survival
-
doi:10.1016/j.clbc.2012.05.001
-
Gradishar, W.J., Krasnojon, D., Cheporov, S.V., Makhson, A.N., Manikhas, G.M., Clawson, A., & Iglesias, J. (2012). A phase II trial of nab-paclitaxel compared with docetaxel as first-line chemotherapy in patients with metastatic breast cancer: Final analysis of overall survival. Clinical Breast Cancer, 12, 313-321. doi:10.1016/j.clbc.2012.05.001
-
(2012)
Clinical Breast Cancer
, vol.12
, pp. 313-321
-
-
Gradishar, W.J.1
Krasnojon, D.2
Cheporov, S.V.3
Makhson, A.N.4
Manikhas, G.M.5
Clawson, A.6
Iglesias, J.7
-
18
-
-
32944482677
-
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer
-
doi:10.1200/JCO.2005.04.937
-
Gradishar, W.J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P.,... O'Shaughnessy, J. (2005). Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. Journal of Clinical Oncology, 23, 7794-7803. doi:10.1200/JCO.2005.04.937
-
(2005)
Journal of Clinical Oncology
, vol.23
, pp. 7794-7803
-
-
Gradishar, W.J.1
Tjulandin, S.2
Davidson, N.3
Shaw, H.4
Desai, N.5
Bhar, P.6
O'Shaughnessy, J.7
-
19
-
-
84863035912
-
-
1975-2009
-
Howlader, N., Noone, A.M., Krapcho, M., Neyman, N., Aminou, R., Altekruse, S.F.,... Cronin, K.A. (Eds.). (2012). SEER cancer statistics review, 1975-2009. Retrieved from http://seer.cancer.gov/csr/1975_2009_pops09
-
(2012)
SEER Cancer Statistics Review
-
-
Howlader, N.1
Noone, A.M.2
Krapcho, M.3
Neyman, N.4
Aminou, R.5
Altekruse, S.F.6
Cronin, K.A.7
-
20
-
-
0018837119
-
Complement-mediated reactions to diazepam with Cremophor as solvent (steroid MR)
-
Huttel, M.S., Olesen, A.S., & Stoffersen, E. (1980). Complement-mediated reactions to diazepam with Cremophor as solvent (steroid MR). British Journal of Anasthesiology, 52, 77-79.
-
(1980)
British Journal of Anasthesiology
, vol.52
, pp. 77-79
-
-
Huttel, M.S.1
Olesen, A.S.2
Stoffersen, E.3
-
21
-
-
0037216440
-
Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer
-
doi:10.1152/ajplung.00152.2002
-
John, T.A., Vogel, S.M., Tiruppathi, C., Malik, A.B., & Minshall, R.D. (2003). Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer. American Journal of Physiology: Lung Cellular and Molecular Physiology, 284, L187-L196. doi:10.1152/ajplung.00152.2002
-
(2003)
American Journal of Physiology: Lung Cellular and Molecular Physiology
, vol.284
-
-
John, T.A.1
Vogel, S.M.2
Tiruppathi, C.3
Malik, A.B.4
Minshall, R.D.5
-
22
-
-
24944507764
-
Randomized phase III study of docetaxel compared with paclitaxel in MBC
-
doi:10.1200/JCO.2005.02.027
-
Jones, S.E., Erban, J., Overmoyer, B., Budd, G.T., Hutchins, L., Lower, E., & Ravdin, P.M. (2005). Randomized phase III study of docetaxel compared with paclitaxel in MBC. Journal of Clinical Oncology, 23, 5542-5551. doi:10.1200/JCO.2005.02.027
-
(2005)
Journal of Clinical Oncology
, vol.23
, pp. 5542-5551
-
-
Jones, S.E.1
Erban, J.2
Overmoyer, B.3
Budd, G.T.4
Hutchins, L.5
Lower, E.6
Ravdin, P.M.7
-
23
-
-
1942438028
-
Microtubules as a target for anticancer drugs
-
Jordan, M.A., & Wilson, L. (2004) Microtubules as a target for anticancer drugs. Nature Reviews Cancer, 4, 253-265.
-
(2004)
Nature Reviews Cancer
, vol.4
, pp. 253-265
-
-
Jordan, M.A.1
Wilson, L.2
-
24
-
-
0030765910
-
Pharmacokinetics of the taxanes
-
Kearns, C.M. (1997). Pharmacokinetics of the taxanes. Pharmacotherapy, 17(5, Pt. 2), 105S-109S.
-
(1997)
Pharmacotherapy
, vol.17
, Issue.5 PART. 2
-
-
Kearns, C.M.1
-
25
-
-
34447107974
-
The shape of things to come: Structural and synthetic studies of taxol and related compounds
-
doi:10.1016/j.phytochem.2006.11.009
-
Kingston, D.G. (2007). The shape of things to come: Structural and synthetic studies of taxol and related compounds. Phytochemistry, 68, 1844-1854. doi:10.1016/j.phytochem.2006.11.009
-
(2007)
Phytochemistry
, vol.68
, pp. 1844-1854
-
-
Kingston, D.G.1
-
26
-
-
0025961818
-
Intreraction of Cremophor-EL with human plasma
-
Kongshaug, M., Cheng, L.S., Moan, J., & Rimington, C. (1991). Intreraction of Cremophor-EL with human plasma. International Journal of Biochemistry, 23, 473-478.
-
(1991)
International Journal of Biochemistry
, vol.23
, pp. 473-478
-
-
Kongshaug, M.1
Cheng, L.S.2
Moan, J.3
Rimington, C.4
-
27
-
-
84887818692
-
-
Lodish, H., Berk, A., Zipursky, S.L., Matsudaira, P., Baltimore, D., & Darnell, J. (2000). Microtubule dynamics and associated proteins. Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK21522
-
(2000)
Microtubule Dynamics and Associated Proteins
-
-
Lodish, H.1
Berk, A.2
Zipursky, S.L.3
Matsudaira, P.4
Baltimore, D.5
Darnell, J.6
-
28
-
-
0034000453
-
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review
-
doi:10.1016/S0168-3659(99)00248-5
-
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000). Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. Journal of Controlled Release, 65, 271-284. doi:10.1016/S0168-3659(99)00248-5
-
(2000)
Journal of Controlled Release
, vol.65
, pp. 271-284
-
-
Maeda, H.1
Wu, J.2
Sawa, T.3
Matsumura, Y.4
Hori, K.5
-
29
-
-
78650254061
-
Production of the anticancer drug Taxol in Taxus baccata suspension cultures: A review
-
doi:10.1016/j.procbio.2010.09.004
-
Malik, S., Cusido, R.M., Mirjalili, M.H., Moyano, E., Palazon, J., & Bonfill, M. (2011). Production of the anticancer drug Taxol in Taxus baccata suspension cultures: A review. Process Biochemistry, 46, 23-34. doi:10.1016/j.procbio.2010.09.004
-
(2011)
Process Biochemistry
, vol.46
, pp. 23-34
-
-
Malik, S.1
Cusido, R.M.2
Mirjalili, M.H.3
Moyano, E.4
Palazon, J.5
Bonfill, M.6
-
30
-
-
0022858683
-
A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs
-
Matsumura, Y., & Maeda, H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs. Cancer Research, 46, 6387-6392.
-
(1986)
Cancer Research
, vol.46
, pp. 6387-6392
-
-
Matsumura, Y.1
Maeda, H.2
-
31
-
-
0031833541
-
Evaluation of the linearity of docetaxel pharmacokinetics
-
McLeod, H.L., Kearns, C.M., Kuhn, J.G., & Bruno, R. (1998). Evaluation of the linearity of docetaxel pharmacokinetics. Cancer Chemotherapy and Pharmacology, 42, 155-159.
-
(1998)
Cancer Chemotherapy and Pharmacology
, vol.42
, pp. 155-159
-
-
McLeod, H.L.1
Kearns, C.M.2
Kuhn, J.G.3
Bruno, R.4
-
32
-
-
8944245005
-
Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer
-
Nabholtz, J.M., Gelmon, K., Bontenbal, M., Spielmann, M., Catimel, G., Conte, P.,... Winograd, B. (1996). Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer. Journal of Clinical Oncology, 14, 1858-1867.
-
(1996)
Journal of Clinical Oncology
, vol.14
, pp. 1858-1867
-
-
Nabholtz, J.M.1
Gelmon, K.2
Bontenbal, M.3
Spielmann, M.4
Catimel, G.5
Conte, P.6
Winograd, B.7
-
33
-
-
0032949449
-
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with MBC progressing despite previous anthracycline-containing chemotherapy. 304 Study Group
-
Nabholtz, J.M., Senn, H.J., Bezwoda, W.R., Melnychuk, D., Deschenes, L., Douma, J.,... Aapro, M. (1999). Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with MBC progressing despite previous anthracycline-containing chemotherapy. 304 Study Group. Journal of Clinical Oncology, 17, 1413-1424.
-
(1999)
Journal of Clinical Oncology
, vol.17
, pp. 1413-1424
-
-
Nabholtz, J.M.1
Senn, H.J.2
Bezwoda, W.R.3
Melnychuk, D.4
Deschenes, L.5
Douma, J.6
Aapro, M.7
-
34
-
-
80051916417
-
Current perspectives on potential role of albumin in neuroprotection
-
doi:10.1515/RNS.2011.028
-
Prajapati, K.D., Sharma, S.S., & Roy, N. (2011). Current perspectives on potential role of albumin in neuroprotection. Reviews in the Neurosciences, 22, 355-363. doi:10.1515/RNS.2011.028
-
(2011)
Reviews In the Neurosciences
, vol.22
, pp. 355-363
-
-
Prajapati, K.D.1
Sharma, S.S.2
Roy, N.3
-
37
-
-
0018387446
-
Promotion of microtubule assembly in vitro by Taxol
-
Schiff, P.B., Fant, J., & Horwitz, S.B. (1979). Promotion of microtubule assembly in vitro by Taxol. Nature, 277, 665-667.
-
(1979)
Nature
, vol.277
, pp. 665-667
-
-
Schiff, P.B.1
Fant, J.2
Horwitz, S.B.3
-
38
-
-
43249115659
-
Randomized phase III trial of weekly compared with every-three-weeks paclitaxel for MBC, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: Final results of Cancer and Leukemia Group B protocol 9840
-
doi:10.1200/JCO.2007.11.6699
-
Seidman, A.D., Berry, D., Cirrincione, C., Harris, L., Muss, H., Marcom, P.K.,... Hudis, C. (2008). Randomized phase III trial of weekly compared with every-three-weeks paclitaxel for MBC, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: Final results of Cancer and Leukemia Group B protocol 9840. Journal of Clinical Oncology, 26, 1642-1649. doi:10.1200/JCO.2007.11.6699
-
(2008)
Journal of Clinical Oncology
, vol.26
, pp. 1642-1649
-
-
Seidman, A.D.1
Berry, D.2
Cirrincione, C.3
Harris, L.4
Muss, H.5
Marcom, P.K.6
Hudis, C.7
-
39
-
-
0036605666
-
Transcytosis of plasma macromolecules in endothelial cells: A cell biological survey
-
Simionescu, M., Gafencu, A., & Antohe, F. (2002). Transcytosis of plasma macromolecules in endothelial cells: A cell biological survey. Microscopy Research and Technique, 57, 269-288.
-
(2002)
Microscopy Research and Technique
, vol.57
, pp. 269-288
-
-
Simionescu, M.1
Gafencu, A.2
Antohe, F.3
-
40
-
-
0034175066
-
Taxanes for breast cancer: An evidence-based review of randomized phase II and phase III trials
-
Sparano, J.A. (2000). Taxanes for breast cancer: An evidence-based review of randomized phase II and phase III trials. Clinical Breast Cancer, 1, 32-40.
-
(2000)
Clinical Breast Cancer
, vol.1
, pp. 32-40
-
-
Sparano, J.A.1
-
41
-
-
42249083269
-
Weekly paclitaxel in the adjuvant treatment of breast cancer
-
doi:10.1056/NEJMoa0707056
-
Sparano, J.A., Wang, M., Martino, S., Jones, V., Perez, E.A., Saphner, T., & Davidson, N.E. (2008). Weekly paclitaxel in the adjuvant treatment of breast cancer. New England Journal of Medicine, 358, 1663-1671. doi:10.1056/NEJMoa0707056
-
(2008)
New England Journal of Medicine
, vol.358
, pp. 1663-1671
-
-
Sparano, J.A.1
Wang, M.2
Martino, S.3
Jones, V.4
Perez, E.A.5
Saphner, T.6
Davidson, N.E.7
-
42
-
-
0033118955
-
Cremophor EL-mediated alteration of paclitaxel distribution in human blood: Clinical pharmacokinetic implications
-
Sparreboom, A., van Zuylen, L., Brouwer, E., Loos, W.J., de Bruijn, P., Gelderblom, H., & Verweij, J. (1999). Cremophor EL-mediated alteration of paclitaxel distribution in human blood: Clinical pharmacokinetic implications. Cancer Research, 59, 1454-1457.
-
(1999)
Cancer Research
, vol.59
, pp. 1454-1457
-
-
Sparreboom, A.1
van Zuylen, L.2
Brouwer, E.3
Loos, W.J.4
de Bruijn, P.5
Gelderblom, H.6
Verweij, J.7
-
43
-
-
0030842545
-
Plasma protein (albumin) catabolism by the tumor itself-Implications for tumor metabolism and the genesis of cachexia
-
Stehle, G., Sinn, H., Wunder, A., Schrenk, H.H., Stewart, J.C.M., Gartung, G.,... Heene, D.L. (1997). Plasma protein (albumin) catabolism by the tumor itself-Implications for tumor metabolism and the genesis of cachexia. Critical Reviews in Oncology Hematology, 26, 77-100.
-
(1997)
Critical Reviews In Oncology Hematology
, vol.26
, pp. 77-100
-
-
Stehle, G.1
Sinn, H.2
Wunder, A.3
Schrenk, H.H.4
Stewart, J.C.M.5
Gartung, G.6
Heene, D.L.7
-
44
-
-
0041703019
-
Pharmacological effects of formulation vehicles: Implications for cancer chemotherapy
-
ten Tije, A.J., Verweij, J., Loos, W.J., & Sparreboom, A. (2003). Pharmacological effects of formulation vehicles: Implications for cancer chemotherapy. Clinical Pharmacokinetics, 42, 665-685.
-
(2003)
Clinical Pharmacokinetics
, vol.42
, pp. 665-685
-
-
ten Tije, A.J.1
Verweij, J.2
Loos, W.J.3
Sparreboom, A.4
-
45
-
-
0017742392
-
Adverse reactions in intravenous anasthetic induction agents
-
Watkins, J., Ward, A.M., & Appleyard, T.N. (1997). Adverse reactions in intravenous anasthetic induction agents. BMJ, 2, 1084-1085.
-
(1997)
BMJ
, vol.2
, pp. 1084-1085
-
-
Watkins, J.1
Ward, A.M.2
Appleyard, T.N.3
-
46
-
-
0016648079
-
Mechanism of action of vinblastine. Binding of [acetyl-3H]-vinblastine to embryonic chick brain tubulin and tubulin from sea urchin sperm tail outer doublet microtubules
-
Wilson, L., Creswell, K.M., & Chin, D. (1975). Mechanism of action of vinblastine. Binding of [acetyl-3H]-vinblastine to embryonic chick brain tubulin and tubulin from sea urchin sperm tail outer doublet microtubules. Biochemistry, 14, 5586-5592.
-
(1975)
Biochemistry
, vol.14
, pp. 5586-5592
-
-
Wilson, L.1
Creswell, K.M.2
Chin, D.3
-
47
-
-
0028328762
-
Potential neurotoxicity of the solvent vehicle for cyclosporine
-
Windebank, A.J., Blexrud, M.D., & de Groen, P.C. (1994). Potential neurotoxicity of the solvent vehicle for cyclosporine. Journal of Pharmacology and Experimental Therapeutics, 268, 1051-1056.
-
(1994)
Journal of Pharmacology and Experimental Therapeutics
, vol.268
, pp. 1051-1056
-
-
Windebank, A.J.1
Blexrud, M.D.2
de Groen, P.C.3
|